✦ LIBER ✦

Response to buserelin (HOE 766) with and without antiandrogens in advanced prostatic cancer

✍ Scribed by M. Cikes; M. Bonard; P. Douglas; P. Jichlinski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced prostate cancer wi

✍ Maffezzini, M.; Broglia, L.; Ronchi, F.; Colombo, R.; Rigatti, P. 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 133 KB

Suppression of testicular steroidogenesi

✍ G. Tolis; N. Faure; M. Koutsilieris; A. Lemay; S. Klioze; A. Yakabow; A.T.A. Faz 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Prostate-specific antigen doubling time

✍ Michael J Shulman; Jose A Karam; Elie A Benaim 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Prostate specific antigen doubling time

✍ Michael J Shulman; Jose A Karam; Elie A Benaim 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Dramatic Prostate Specific Antigen Decre

✍ Dawson, Nancy A.; McLeod, David G. 📂 Article 📅 1995 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 268 KB

Experience with flutamide in patients wi

✍ Pramod C. Sogani; Minoo R. Vagaiwala; Willet F. Whitmore Jr. 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB